French Registry Study Shows One-Month CAR-T Response Doesn’t Predict Final Outcome
A French nationwide registry analysis of 1,542 adults with large B-cell lymphoma clarifies how response evolves after CD19 CAR-T therapy. At one month, 49.1% of patients were in complete remission, while 35.5% of the…
